The OS and DS rates of luminal B BC were 89.10 and 82.21%, respectively; those of HER2-positive BC were 70.20 and 51.11%, respectively, and those of TNCB were 81.20 and 75.20%, respectively. Here, ERBB2 is linked to breast cancer.